⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Gut Microbiota and Healthspan
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-12 — Metabolic exploitation of the bacterial arginine deiminase pathway extends Caenorhabditis elegans healthspan: [animal-model] A C. elegans study links live Lactococcus lactis JCM 5805–mediated lifespan extension to bacterial arginine deiminase, gut L-citrulline production, and preserved cuticle collagen integrity, identifying a specific microbial metabolic function rather than a composition-only association without establishing human probiotic or longevity benefits. [animal-model] (novelty: 3)
- 2026-11-09 — TMAO regulates renal tubular epithelial cell senescence through circVmn2r1.: [animal-model] Mouse and tubular epithelial cell experiments identify a TMAO–circVmn2r1–NLRP3 pathway promoting renal senescence and kidney-aging phenotypes, adding a gut-associated metabolite-to-kidney mechanism without demonstrating that microbiota modification prevents renal aging or extends human healthspan. [animal-model] (novelty: 3)
- 2026-10-07 — Gut microbiota alterations associated with dietary inflammation and sarcopenia in humans and aged mice: insights from integrated metabolomic analysis.: [human-observational] A cohort analysis of 1,048 older adults associated higher dietary inflammatory index with sarcopenia and reported gut microbial alterations, without establishing microbial mediation or showing that microbiota-targeted treatment preserves human muscle. [human-observational] (novelty: 3)
- 2026-10-26 — Cardiovascular resilience in centenarians.: [expert-opinion] Review, no new primary microbiome data: a gut microbiome characterized as youthful is proposed as one contributor to centenarian cardiovascular resilience, without establishing whether this composition causes protection, reflects survivor selection, or can be therapeutically reproduced to prevent human cardiovascular events. [expert-opinion] (novelty: 3)
- 2026-09-29 — Westlake Longevity Cohort: 2026 Westlake Longevity Cohort (We-Longevity) protocol: prospective Chinese centenarian/nonagenarian/senior cohort that will pair multi-omics with culturomics of gut microbiota and link diet/lifestyle to molecular profiles — a planned culturomics-plus-multi-omics resource for the microbiota–longevity axis, no readouts yet. [human-observational] (novelty: 3)
- 2026-10-01 — Precision Microbiota Interventions for Senoreduction Trial: Randomized double-blind crossover trial testing two GRAS microbiota-targeted interventions in people with HIV who use alcohol, with immune-senescence biomarkers as the readout — adds a precision-microbiota ‘senoreduction’ trial design in an accelerated-aging human population to the microbiota-and-healthspan trial roster, no results yet. [human-rct] (novelty: 3)
- 2026-07-17 — Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer’s and Parkinson’s disease.: 2026 critical review frames Urolithin A as a microbiota-derived ellagitannin metabolite whose bioavailability depends on individual gut microbial composition (urolithin-producer status), reinforcing the microbe-as-bioconverter template and nominating stratification by producer phenotype as an under-addressed design gap in neuro-trial translation — synthesis, no new microbiome data. [expert-opinion] (novelty: 3)
- 2026-10-01 — Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.: 2026 90-day double-blind RCT (n=140, adults ≥60) of Polygonatum odoratum shifted gut microbiota (↑Akkermansia, ↑Prevotella 9, ↓Klebsiella) with concurrent immune and respiratory-infection improvements, extending the human microbiota-modulating-herb catalog with a composition-level readout tied to an infection endpoint. [human-rct] (novelty: 3)
- 2026-07-12 — Biological limits of lifespan extension: Evidence for a shift from pathway leverage to system-level buffering across species.: 2026 comparative-limits synthesis cites microbiota-host crosstalk as one of the distributed buffering systems that dilutes single-pathway interventions in mammals, framing the gut axis as part of the redundancy that mutes conserved-pathway leverage above invertebrate models — narrative framing, no new microbiome data. [expert-opinion] (novelty: 3)
- 2026-07-21 — β-Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota-bile acid-farnesoid X receptor (FXR/NR1H4) axis.: 2026 mouse AFB1 study shows oral NMN reshapes gut microbiota and raises BSH activity en route to intestinal FXR/FGF15 activation and liver protection — adds NMN to the catalog of host-ingested agents whose aging-relevant effects route through microbiota remodeling, mouse-only with causal antibiotic/FMT/FXR-KO support. [animal-model] (novelty: 3)
- 2026-08-18 — The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.: 2026 nutrition–sleep–circadian–neurodegeneration review folds the gut–brain axis into a four-pathway substrate for age-related neurodegeneration driven by circadian/nutritional misalignment, invoking microbiota-shaped signals as upstream contributors modifiable by chrononutrition and Mediterranean-pattern diet — narrative synthesis, no primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-07-19 — The circulating senosome: Blood as the therapeutic interface of aging.: 2026 ‘circulating senosome’ review explicitly incorporates microbiome-derived products (metabolites, microbial nucleic acids) as a constitutive arm of the blood-borne aging mediator network, placing gut-origin circulating signals on equal footing with host SASP and EVs within a shared systemic interface; synthesis, no new microbiome data. [mechanism-plausible] (novelty: 3)
- 2026-08-10 — Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.: 2026 CSDH geroscience minireview includes dysbiosis among the twelve extended hallmarks mapped onto chronic subdural hematoma, framed as a weaker candidate contributor relative to inflammation and altered intercellular communication — review-level inclusion, no CSDH-specific microbiome data. [expert-opinion] (novelty: 3)
- 2026-08-18 — Multivariable-adjusted multi-omics signatures reveal gut microbial functional alterations and metabolic dysregulation in intrinsic capacity decline.: 2026 multi-omics observational study in older adults (fecal metagenomics + serum metabolomics, adjusted for age, sex, comorbidity, diet): intrinsic capacity decline associated with 57 gut bacterial species and 56 serum metabolites, with a structured microbiome–metabolome network implicating amino-acid, carnitine, bile-acid, and senescence-related metabolites — adds a rigorously-adjusted human IC-decline signature to the microbiota–healthspan evidence stack, no causal manipulation. [human-observational] (novelty: 3)
- 2026-09-28 — The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.: 2026 4-week double-blind placebo-controlled RCT (n=29 completers) in frail older adults: low-methoxy pectin supplementation improved 30-s sit-to-stand, anxiety/depression scores, and several SF-36 domains, and enriched gut Coprococcus comes, without changing circulating inflammatory biomarkers — small, short, underpowered human signal that a specific fermentable fibre shifts microbiota alongside physical and mood endpoints, with the inflammaging link conspicuously absent. [human-rct] (novelty: 3)
- 2026-09-28 — Butyrate-producing gut microbiota modifies the association between dietary protein density and functional recovery after stroke.: 2026 post-stroke rehabilitation cohort of older adults: butyrate-producing gut taxa modified the association between dietary protein density and ADL-based motor functional recovery, extending the microbe-as-modifier framing from metabolic/muscle endpoints to post-acute neurological rehabilitation — observational interaction, no causal manipulation. [human-observational] (novelty: 3)
- 2026-10-01 — Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.: 2026 TCM-formulas-and-aging review names gut-microbiota modulation among the convergent mechanisms by which multi-herb TCM formulas delay aging, consolidating preclinical formula effects on composition and microbe-derived metabolites without new primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-09-17 — Ecosystem Nourishment for Gut Restoration After Fecal Transplantation: 2026 four-arm RCT protocol tests young-donor FMT, a fermented plant-rich high-fiber ‘microbiome rejuvenating diet,’ or both in adults ≥40, pairing microbiota rebuilding with substrate ecosystem nourishment against inflammatory and biological-age readouts — protocol only, no results, and one of the first designs to factorially separate donor-microbe delivery from dietary niche construction. [human-rct] (novelty: 3)
- 2026-09-23 — Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape: 2026 pig FMT study: transplanting elderly human gut microbiota into pigs reprogrammed intestinal barrier function, plasma metabolome, and gut mucosal transcriptome — adds large-animal causal evidence that aged human microbiota transmits host phenotypes, moving beyond rodent FMT models but still preclinical. [animal-model] (novelty: 3)
- 2026-09-15 — The Oral Microbiome-Inflammaging Axis in Elderly Periodontitis: Emerging Immunopathogenic and Systemic Mechanisms.: 2026 elderly-periodontitis synthesis extends the microbiome–healthspan frame to the oral cavity, arguing oral dysbiosis operates as a parallel (and possibly upstream) contributor to systemic inflammaging alongside gut dysbiosis in older adults — narrative synthesis, no new microbiome data. [expert-opinion] (novelty: 3)
- 2026-09-26 — The Eukaryotic Host-Microbe-Phage-Nutrition Interplay Determines the Bacterial Effectors of Supplemental Lysine’s Health Benefits: An Experimental Cellular Senescence Model of Digestive Conditions in Older Adults.: 2026 preclinical cellular model layering senescent vs young gut epithelium with a pathogen, a phage, and a beneficial anaerobe: supplemental lysine’s benefit or harm flips depending on host–microbe–phage interactions and cross-feeding — extends the microbe-as-modifier framing to an established amino-acid supplement, cell-culture only. [mechanism-plausible] (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: 2026 matched case-control study in older adults links specific serum bile acids (3β-HDCA, GLCA, TLCA) to sarcopenia and gait speed, with a sleep-duration interaction on TLCA — adds a human observational data point implicating bile-acid pool composition (a microbiota-shaped output) in muscle aging. [human-observational] (novelty: 3)
- 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: 2026 aging-mouse Western-diet study: probiotic strain CL256B, selected for efficient hesperidin→hesperetin bioconversion, improved metabolic health, hepatic steatosis, and grip strength via a CISD2/SIRT1 axis — extends the microbe-as-bioconverter template (analogous to equol, urolithin producers) to a citrus flavonoid, mouse only. [animal-model] (novelty: 3)
- 2026-09-18 — Ferroptosis and Ferro-Aging in Obesity: Bibliometric Mapping, Shared Mechanisms, and Translational Perspectives.: 2026 obesity–ferroptosis review touches gut-derived iron handling and microbiota-modulated systemic iron/lipid milieu as one plausible upstream contributor to the obese pro-ferroperoxidative state, a peripheral mention within a bibliometric synthesis rather than a primary microbiome finding. [expert-opinion] (novelty: 3)
- 2026-09-22 — Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.: 2026 integrative review frames anti-aging diets (CR, Mediterranean, ketogenic, polyphenol- and fiber-enriched patterns) plus moderate exercise as convergent modulators of gut microbiota composition and LPS/SCFA output relevant to musculoskeletal aging — narrative synthesis of mostly preclinical and small-human studies, no primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-06-08 — ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.: 2026 male-mouse study identifies hepatic ACAT3 as an upstream cholesterol-esterifying enzyme whose loss reshapes bile-acid output and gut microbiota composition, adding a liver-genetic entry point to the host→microbiota arm of the axis; expression is reported to decline with aging, obesity, and diabetes, mouse-only. [animal-model] (novelty: 3)
- 2026-09-15 — The canine gut microbiome as a translational model for human health and aging.: 2026 review positions the domestic dog as a complementary translational model for the gut microbiome–aging axis, arguing shared environments, spontaneous age-related disease, and a compressed lifespan enable longitudinal microbiome sampling that is impractical in humans — synthesis/framing, no new primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-09-14 — GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.: 2026 GLP-1 RA geroprotection review invokes gut–brain GLP-1 signaling and microbiota-derived modulation of enteroendocrine GLP-1 release as part of the mechanistic case for these drugs as gerotherapeutics — conceptual framing, no new microbiome data. [expert-opinion] (novelty: 3)
- 2026-09-10 — EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.: Pilot single-arm trial of low-dose rapamycin (1 mg/day × 4 weeks) in APOE4 carriers reports concurrent shifts in gut microbiome profile alongside cerebrovascular and metabolic changes — first human signal that oral mTOR inhibition perturbs the microbiota in a genotype-stratified midlife cohort, uncontrolled. [human-rct] (novelty: 3)
- 2026-07-15 — Cinnamon polysaccharides reshape gut microbiota and enrich Alloprevotella rava to promote acetate-dependent choline metabolism and delay mammary aging.: 2026 mouse study: cinnamon polysaccharide supplementation enriched Alloprevotella rava, whose acetate output improved host choline utilisation and delayed mammary tissue senescence, with knock-on benefits to offspring brain development — extends the microbe-metabolite-host axis catalog to a gut→mammary node, mouse only. [animal-model] (novelty: 3)
- 2026-09-10 — NAD+ Metabolic Reprogramming Drives CD8+ T Cells Senescence and Exacerbates Ulcerative Colitis: cross-connection with immunosenescence: Ties T-cell immunosenescence mechanistically to a gut-barrier/mucosal inflammatory disease (UC), suggesting T-cell senescence as a candidate substrate for the observed dysbiosis→IBD-severity axis. (novelty: 3)
- 2026-08-10 — HB05P on Muscle Health: 2026 HB05P pilot RCT protocol: 24-week trial testing daily pasteurized Akkermansia muciniphila HB05 (3×10^10 cells) plus routine walking/resistance exercise vs. exercise alone in adults 50–80 with sarcopenia or possible sarcopenia, with isokinetic leg strength as primary endpoint — protocol registration only, no readout yet, and first clinical test of a pasteurized Akkermansia postbiotic specifically for the microbiota–muscle axis. [human-rct] (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: Planned human FMT trial delivering lyophilized fecal microbiota capsules from young, physically active donors to older adults, with muscle, cognitive, and metabolic function endpoints — protocol/project description only, no readout yet. [human-rct] (novelty: 3)
- 2026-08-31 — Acetate and Age-associated Arterial Dysfunction: 2026 acetate RCT protocol proposes direct oral SCFA (acetate) supplementation as a fiber-independent route to engage the gut–SCFA–vascular axis in adults 50+ — planned trial, no readout yet. [human-rct] (novelty: 3)
- 2026-09-04 — Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging: 2026 Aging Cell review consolidates Akkermansia muciniphila and its bioactive derivatives (Amuc_1100, extracellular vesicles, pasteurized cells) as emerging healthy-aging regulators acting via mucin-layer/gut-barrier reinforcement, metabolic and inflammaging modulation — synthesis of prior preclinical and early human work, no new primary data. [expert-opinion] (novelty: 3)
- 2026-03-17 — Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization?: 2026 narrative review reframes gut microbiota resilience (capacity to resist and recover from environmental perturbation) — not dysbiosis per se — as an underexplored healthspan/longevity determinant, cataloging diet, microbial therapeutics, behavioral, and multi-omics precision levers; conceptual reframing, no new primary data. [expert-opinion] (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: 2026 GLAM-framework review incorporates the gut as one node of a four-organ (gut–liver–adipose–muscle) metabolic-inflammatory axis feeding sarcopenia, framing dysbiosis-driven signals as upstream contributors to muscle aging — synthesis, no primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: 2026 dietary-peptide review lists gut microbiota remodeling as one of the shared mechanisms by which food-derived bioactive peptides may act as geroprotectors, adding peptides to the substrate catalog upstream of the microbiota–healthspan axis — synthesis only, no primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-06-26 — A novel role for magnetotactic bacterium: Magnetospirillum magneticum AMB-1 prolonged healthy lifespan of Caenorhabditis elegans via regulating ferroptosis.: 2026 C. elegans study: dietary Magnetospirillum magneticum AMB-1 (a magnetotactic bacterium) extended mean lifespan ~43% via host ferroptosis suppression (ftn-1↑, bli-3↓, ads-1-dependent) — extends the microbe-as-geroprotector catalog to a non-probiotic environmental bacterium, nematode-only. [animal-model] (novelty: 3)
- 2026-06-27 — Long-term selection for extended lifespan reshapes host physiology and gut microbiome structure in an insect model.: 2026 house cricket study: >30 generations of selection for delayed reproduction/extended lifespan co-segregated with larger body size and shifted gut microbiome composition (Gammaproteobacteria and lactic acid bacteria enrichment) without reduced food intake, lower antioxidant capacity, or elevated DNA damage — correlational, causal microbiome–lifespan link not established, insect model. [animal-model] (novelty: 3)
- 2026-08-01 — Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights.: 2026 hepatic-ammonia review invokes a liver–gut axis in which microbiota-derived ammonia loading intersects with declining hepatic urea-cycle capacity to raise systemic ammonia, framing gut microbes as a modifiable upstream source in liver-centric aging — conceptual, no new microbiome data. [mechanism-plausible] (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: 2026 cardiometabolic-aging review argues age-related gut dysbiosis (altered SCFA/TMAO/bile-acid output) contributes to cardiac senescence via a gut–heart axis, positioning microbiota modulation among the nodal interventions for cardiac aging — narrative synthesis, no primary microbiome data. [expert-opinion] (novelty: 3)
- 2026-08-25 — A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan.: 2026 study nominates Bifidobacterium pseudocatenulatum and its metabolite 5-AVAB as a geroprotective gut-microbe/metabolite axis: supplementation extended healthspan and dampened multi-organ inflammaging in naturally aged mice, and the species declined with age across Chinese cohorts (also introducing a MicroAge microbiome clock). [animal-model] (novelty: 4)
- 2026-07-06 — Microbiome and aging: Trajectories of microbiome age across human ecosystems and their systemic effects.: 2026 integrative review consolidates gut microbiome trajectories with oral/skin/urogenital communities into a unified ‘microbiome age’ framework, positioning gut dysbiosis as one habitat within a multi-ecosystem systemic aging signal rather than a standalone axis — synthesis, no new primary data. [expert-opinion] (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: 2026 hierarchy review touches microbiota-mediated dysbiosis as a downstream tier interacting with primary insults, arguing microbiome-directed strategies fit into a coordinated multi-target prevention frame rather than a standalone lever — mention within a conceptual reorganization, no new microbiome data. [expert-opinion] (novelty: 3)
- 2026-07-01 — Gut Metabolism Links Precision Nutrition, Exercise, and Healthspan in Drosophila melanogaster.: 2026 Drosophila study: Lactiplantibacillus plantarum abundance and gut redox homeostasis partially mediate the additive lifespan and locomotor benefits of methionine restriction + taurine + moderate exercise — partial causal support in flies only. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Metabolic syndrome and Alzheimer's disease: Mechanistic links and precision prevention (Review).
13-nov-2026
novelty 2
per-area 2
strengthens
The Gut Microbiome in Aging
13-nov-2026
novelty 2
per-area 2
mentions
Metabolic exploitation of the bacterial arginine deiminase pathway extends Caenorhabditis elegans healthspan
12-nov-2026
novelty 3
per-area 3
strengthens
Reframing the gut-muscle axis through the lens of functional redundancy: A conceptual framework for chronic sarcopenia, acute muscle wasting, and microbiota-related interventions.
12-nov-2026
novelty 2
per-area 2
strengthens
How dsm-firmenich Is Linking Gut Health, Healthy Longevity, and Better-Tasting Supplements
10-nov-2026
novelty 2
per-area 1
mentions
TMAO regulates renal tubular epithelial cell senescence through circVmn2r1.
09-nov-2026
novelty 3
per-area 3
strengthens
Cardiovascular resilience in centenarians.
26-oct-2026
novelty 3
per-area 3
strengthens
Dietary Equisetum arvense Polysaccharides Alleviate Obesity in Aged Mice Associated with Altered Gut Microbiota.
23-oct-2026
novelty 2
per-area 2
strengthens
Qi-Fu-Yin Attenuates Frailty by Regulating Gut Microbiota and Neuroendocrine Hormones in 5xFamilial Alzheimer's Disease Transgenic Mice.
09-oct-2026
novelty 2
per-area 2
strengthens
Is There a Relationship Between the Gut Microbiome and the Functional Capabilities of Skeletal Muscle? A Narrative Review.
08-oct-2026
novelty 2
per-area 3
strengthens
Gut microbiota alterations associated with dietary inflammation and sarcopenia in humans and aged mice: insights from integrated metabolomic analysis.
07-oct-2026
novelty 3
per-area 3
strengthens
Precision Microbiota Interventions for Senoreduction Trial
01-oct-2026
novelty 3
per-area 3
strengthens
Associations Between Gut Microbiota and Immune Profiles in Community-Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum.
01-oct-2026
novelty 3
per-area 3
strengthens
Systemic inflammation, gut microbiome composition, and cognitive performance among older Ugandans with Alzheimer's disease and related dementias: A cross-sectional study.
01-oct-2026
novelty 2
per-area 2
mentions
Extracellular vesicles: Multi-source regulatory mechanisms in hippocampal homeostasis.
01-oct-2026
novelty 2
per-area 2
strengthens
Traditional Chinese Medicine Formulas in Delaying Aging: From Theoretical Foundations to Molecular Mechanisms and Translational Perspectives.
01-oct-2026
novelty 3
per-area 3
strengthens
Traditional Chinese medicine-derived natural products and formulations as pharmacological modulators of ageing-related pathways: mechanisms and therapeutic potential.
01-oct-2026
novelty 2
per-area 2
mentions
Crosstalk between exosomes and cellular senescence: A core vicious loop promoting α-synuclein pathology in Parkinson's disease.
30-sep-2026
novelty 2
per-area 2
mentions
Westlake Longevity Cohort
29-sep-2026
novelty 3
per-area 3
strengthens
The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.
28-sep-2026
novelty 3
per-area 3
strengthens
Butyrate-producing gut microbiota modifies the association between dietary protein density and functional recovery after stroke.
28-sep-2026
novelty 3
per-area 3
strengthens
Ginseng-Schisandra ameliorates D-galactose-induced cognitive impairment in mice: Evidence from gut microbiota and metabolomic analyses.
28-sep-2026
novelty 2
per-area 2
strengthens
The Eukaryotic Host-Microbe-Phage-Nutrition Interplay Determines the Bacterial Effectors of Supplemental Lysine's Health Benefits: An Experimental Cellular Senescence Model of Digestive Conditions in Older Adults.
26-sep-2026
novelty 3
per-area 3
strengthens
Fermented protein foods as modulators of the gut-muscle axis: mechanisms, evidence, and future directions.
25-sep-2026
novelty 2
per-area 2
strengthens
Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape
23-sep-2026
novelty 3
per-area 3
strengthens
Associations Between Gut Microbiota and Immune Profiles in Community‐Dwelling Older Adults and the Regulatory Role of Polygonatum odoratum
23-sep-2026
novelty 2
per-area 2
strengthens
An intestine-centric view of neurodegeneration: How intestine-derived signals mediate the intestine-brain axis to impact Alzheimer's disease.
23-sep-2026
novelty 2
per-area 2
strengthens
Metabolism of Nicotinamide Adenine Dinucleotide+ in Atherosclerosis: Mechanisms and Nutritional Modulation.
23-sep-2026
novelty 2
per-area 2
mentions
A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
23-sep-2026
novelty 3
per-area 3
strengthens
Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.
22-sep-2026
novelty 3
per-area 3
strengthens
Aging of Skeletal Muscle: From Molecular Mechanisms to Therapeutic Interventions.
21-sep-2026
novelty 2
per-area 2
mentions
Mechanisms of Brain Aging and Their Links to Alzheimer's and Parkinson's Disease Pathology.
21-sep-2026
novelty 2
per-area 2
strengthens
Sex-based differences in the gut-metabolism axis in aging and Nrf2-deficient mice.
21-sep-2026
novelty 2
per-area 3
strengthens
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
18-sep-2026
novelty 2
per-area 1
mentions
Ferroptosis and Ferro-Aging in Obesity: Bibliometric Mapping, Shared Mechanisms, and Translational Perspectives.
18-sep-2026
novelty 3
per-area 3
strengthens
Ecosystem Nourishment for Gut Restoration After Fecal Transplantation
17-sep-2026
novelty 3
per-area 3
strengthens
The dimorphic brain in ischemic stroke: How sex and age shape molecular pathophysiology and therapeutic responsiveness.
16-sep-2026
novelty 2
per-area 2
strengthens
The Oral Microbiome-Inflammaging Axis in Elderly Periodontitis: Emerging Immunopathogenic and Systemic Mechanisms.
15-sep-2026
novelty 3
per-area 3
strengthens
The canine gut microbiome as a translational model for human health and aging.
15-sep-2026
novelty 3
per-area 3
strengthens
Development of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing
14-sep-2026
novelty 2
per-area 2
mentions
GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.
14-sep-2026
novelty 3
per-area 3
strengthens
EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial.
10-sep-2026
novelty 3
per-area 3
strengthens
Immunosenescence, inflammaging, and metabolic disease: A geroscience perspective on mechanisms and links.
10-sep-2026
novelty 2
per-area 2
mentions
Effects of Heidihuang Pill on renal fibrosis and senescence-associated changes in rats with unilateral ureteral obstruction: A fecal metabolomics and Klotho-knockdown study.
05-sep-2026
novelty 2
per-area 2
mentions
Effects of Shanyu Pill in Older Adults With Sarcopenia
04-sep-2026
novelty 3
per-area 2
mentions
Akkermansia muciniphila and Its Bioactive Derivatives: Emerging Regulators of Healthy Aging
04-sep-2026
novelty 3
per-area 3
strengthens
Microbiome in Aging of Gut and Brain
02-sep-2026
novelty 2
per-area 2
mentions
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
31-aug-2026
novelty 3
per-area 2
strengthens
Acetate and Age-associated Arterial Dysfunction
31-aug-2026
novelty 3
per-area 3
strengthens
A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan
25-aug-2026
novelty 3
per-area 3
strengthens